Psychedelics
Company announces development of novel intranasal formulation with promising efficacy
Hi, what are you looking for?
Mugglehead Magazine
Science and Research
Medical and Pharmaceutical
New academic journal spotlights potential for rare cannabinoids to treat skin conditions
Business
Dimethyltryptamine continues to demonstrate tremendous therapeutic potential
Industry update
Canadian company set to focus clinical trials down under, announces regulatory update
Psychedelics
As rates of mental health disorders increase the demand for psychedelic treatments do too
CBD
Many distributors are choosing not to test their products for microbes, pesticides and heavy metals
News
Up to 37 per cent experienced positive side effects such as feeling active, energetic, "frisky" or productive
Medical and Pharmaceutical
The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds
Medical and Pharmaceutical
But whether or not the disruption helps with the substance's antidepressant properties still needs further research
Business
The study also found that seven out of ten patients did not suffer from adverse effects
